Skip to main content

Peer Review reports

From: When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report

Original Submission
22 Mar 2023 Submitted Original manuscript
24 May 2023 Reviewed Reviewer Report - Mohankumar Doraiswamy
13 Jun 2023 Reviewed Reviewer Report - Research Square Reviewer 1
29 Jul 2023 Author responded Author comments - Mare Sabbe
Resubmission - Version 2
29 Jul 2023 Submitted Manuscript version 2
2 Aug 2023 Reviewed Reviewer Report - Mohankumar Doraiswamy
7 Aug 2023 Reviewed Reviewer Report - Research Square Reviewer 1
1 Oct 2023 Author responded Author comments - Mare Sabbe
Resubmission - Version 3
1 Oct 2023 Submitted Manuscript version 3
9 Oct 2023 Reviewed Reviewer Report - Research Square Reviewer 1
21 Oct 2023 Reviewed Reviewer Report - Mohankumar Doraiswamy
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
6 Nov 2023 Editorially accepted
31 Jan 2024 Article published 10.1186/s13256-023-04255-8

You can find further information about peer review here.

Back to article page